Invitations to Investors Conferences and Annual Report Filings - Research Report on Haemonetics, Insulet, DexCom, HeartWare, and

  Invitations to Investors Conferences and Annual Report Filings - Research
        Report on Haemonetics, Insulet, DexCom, HeartWare, and Mindray

Editor Note: For more information about this release, please scroll to bottom.

PR Newswire

NEW YORK, June 11, 2013

NEW YORK, June 11, 2013 /PRNewswire/ --

Today, Wall Street Reports announced new research reports highlighting
Haemonetics Corp. (NYSE: HAE), Insulet Corporation (NASDAQ: PODD), DexCom,
Inc. (NASDAQ: DXCM), Heartware International Inc. (NASDAQ: HTWR), and Mindray
Medical International Limited (NYSE: MR). Today's readers may access these
reports free of charge - including full price targets, industry analysis and
analyst ratings - via the links below.

Haemonetics Corp. Research Report

On June 5, 2013, Haemonetics Corp. (Haemonetics) announced that Brian
Concannon, President and Chief Executive Officer of the Company, will present
at The William Blair 33rd Annual Growth Stock Conference in Chicago on June
13, 2013 at 11:00 a.m. ET. The Full Research Report on Haemonetics Corp. -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.WSReports.com/r/full_research_report/7366_HAE]

--

Insulet Corporation Research Report

On May 5, 2013, Insulet Corporation (Insulet), the leader in tubeless insulin
pump technology with its OmniPod Insulin Management System, announced that the
Company will participate at The William Blair Growth Stock Conference to be
held from June 11 to June 13, 2013 at the Four Seasons Chicago. Management is
scheduled to present an overview of the Company on Wednesday, June 12, 2013 at
2:40 p.m. CT (3:40 p.m. ET). During the presentation, material information
concerning the Company, its operations, strategies and prospects may be
discussed. The live audio webcast of the presentation can be accessed at the
Investors Relations section of the Company website. A replay of the webcast
will be available for 10 days from the day of the initial presentation. The
Full Research Report on Insulet Corporation - including full detailed
breakdown, analyst ratings and price targets - is available to download free
of charge at: [http://www.wsreports.com/r/full_research_report/7fe0_PODD]

--

DexCom, Inc. Research Report

On June 4, 2013, DexCom, Inc. (DexCom) announced that Terry Gregg, Chief
Executive Officer, will present an update on the Company at the William Blair
Growth Stock Conference in Chicago on Tuesday, June 11, 2013 at 8:50 a.m.
(CDT). The Company stated that the presentation, which will occur live at the
Four Seasons Hotel, will be concurrently webcast. Further, the Company
informed that a link to the webcast will be available on the DexCom website by
navigating to "About," then "Investor Relations," and then "Events and
Webcasts," and will be archived there for future reference. The Full Research
Report on DexCom, Inc. - including full detailed breakdown, analyst ratings
and price targets - is available to download free of charge at:
[http://www.wsreports.com/r/full_research_report/d67a_DXCM]

--

HeartWare International Inc. Research Report

On June 4, 2013, HeartWare International Inc. (HeartWare) announced that its
Chief Executive Officer, Doug Godshall, is scheduled to present at the Goldman
Sachs 34th Annual Global Healthcare Conference at 8:00 a.m. PDT (11:00 a.m.
EDT) on Wednesday, June 12, 2013. The conference will be held from June 11 to
June 13, 2013 at the Terranea Resort in Rancho Palos Verdes, CA. A live
webcast of the Company's presentation will be accessible via a link provided
at the Company website. A replay of the webcast will also be available for 90
days at the site after the presentation. HeartWare is a leading innovator of
less invasive, miniaturized circulatory support technologies that are
revolutionizing the treatment of advanced heart failure. The Full Research
Report on HeartWare International Inc. - including full detailed breakdown,
analyst ratings and price targets - is available to download free of charge
at: [http://www.wsreports.com/r/full_research_report/086c_HTWR]

--

Mindray Medical International Limited Research Report

On May 21, 2013, Mindray Medical International Limited (Mindray) announced
that it had filed an Annual Report on Form 20-F with the Securities and
Exchange Commission in early April 2013, that included audited financial
statements for the year ended December 31, 2012. An electronic version of
Mindray's Annual Report on Form 20-F is available on Mindray's Investor
Relations website. Mindray is a leading developer, manufacturer and marketer
of medical devices worldwide. The Full Research Report on Mindray Medical
International Limited - including full detailed breakdown, analyst ratings and
price targets - is available to download free of charge at:
[http://www.wsreports.com/r/full_research_report/8545_MR]

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by a CFA. However, we are only human and are prone to
    make mistakes. If you notice any errors or omissions, please notify us
    below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquires, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider has, through Chartered Financial
Analysts, only reviewed the information provided by Equity News Network in
this article or report according to the Procedures outlined by Equity News
Network. Equity News Network is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

SOURCE Wall Street Reports

Contact: WSReports.com Phone #: +1-310-496-8071